Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GOMEZ-REINO, Juan J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2
Export

Selection :

  • and

Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infectionGOMEZ-REINO, Juan J; CARMONA, Loreto; DESCALZO, Miguel Angel et al.Arthritis care and research. 2007, Vol 57, Num 5, pp 756-761, issn 0893-7524, 6 p.Article

Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factorZAMARRON, Carlos; MACEIRAS, Francisco; GONZALEZ, Javier et al.Respiratory medicine. 2004, Vol 98, Num 2, pp 123-125, issn 0954-6111, 3 p.Article

Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosisGARCIA, Samuel; MERA, Antonio; GOMEZ-REINO, Juan J et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 5, pp 483-489, issn 1462-0324, 7 p.Article

Lysophosphatidic Acid Receptor 1 Suppression Sensitizes Rheumatoid Fibroblast-like Synoviocytes to Tumor Necrosis Factor―Induced ApoptosisOROSA, Beatriz; GONZALEZ, Antonio; MERA, Antonio et al.Arthritis and rheumatism. 2012, Vol 64, Num 8, pp 2460-2470, issn 0004-3591, 11 p.Article

Association of Anti―Citrullinated Vimentin and Anti―Citrullinated α-Enolase Antibodies With Subsets of Rheumatoid ArthritisMONTES, Ariana; PEREZ-PAMPIN, Eva; CALAZA, Manuel et al.Arthritis and rheumatism. 2012, Vol 64, Num 10, pp 3102-3110, issn 0004-3591, 9 p.Article

Adiponectin and leptin increase IL-8 production in human chondrocytesGOMEZ, Rodolfo; SCOTECE, Morena; CONDE, Javier et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 11, pp 2052-2054, issn 0003-4967, 3 p.Article

A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosusFERNANDEZ-BLANCO, Lorena; PEREZ-PAMPIN, Eva; GOMEZ-REINO, Juan J et al.Arthritis and rheumatism. 2004, Vol 50, Num 1, pp 328-329, issn 0004-3591, 2 p.Article

Novel DNASE I mutations related to systemic lupus erythematosusBODANO, Ana; AMARELO, Juan; GONZALEZ, Antonio et al.Arthritis and rheumatism. 2004, Vol 50, Num 12, pp 4070-4071, issn 0004-3591, 2 p.Article

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic ReviewRAMON MANEIRO, Jose; SALGADO, Eva; GOMEZ-REINO, Juan J et al.Seminars in arthritis and rheumatism. 2012, Vol 42, Num 1, pp 89-103, issn 0049-0172, 15 p.Article

Expression and Modulation of Ghrelin O-Acyltransferase in Cultured ChondrocytesGOMEZ, Rodolfo; LAGO, Francisca; GOMEZ-REINO, Juan J et al.Arthritis and rheumatism. 2009, Vol 60, Num 6, pp 1704-1709, issn 0004-3591, 6 p.Article

Particular Association of Clinical and Genetic Features With Autoimmunity to Citrullinated α-Enolase in Rheumatoid ArthritisMONTES, Ariana; DIEGUEZ-GONZALEZ, Rebeca; PEREZ-PAMPIN, Eva et al.Arthritis and rheumatism. 2011, Vol 63, Num 3, pp 654-661, issn 0004-3591, 8 p.Article

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR StudyGOMEZ-REINO, Juan J; RAMON MANEIRO, Jose; RUIN, Jorge et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 11, pp 1861-1864, issn 0003-4967, 4 p.Article

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0GOMEZ-REINO, Juan J; RODRIGUEZ-LOZANO, Carlos; CAMPOS-FERNANDEZ, Cristina et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 3, pp 382-385, issn 0003-4967, 4 p.Article

Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's diseaseFERREIROS-VIDAL, Isabel; AMARELO, Juan; BARROS, Francisco et al.Journal of rheumatology. 2003, Vol 30, Num 1, pp 102-104, issn 0315-162X, 3 p.Article

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance reportGOMEZ-REINO, Juan J; CARMONA, Loreto; RODRIGUEZ VALVERDE, Vicente et al.Arthritis and rheumatism. 2003, Vol 48, Num 8, pp 2122-2127, issn 0004-3591, 6 p.Article

Cancer in Patients with Rheumatic Diseases Exposed to TNF AntagonistsCARMONA, Loreto; ABASOLO, Lydia; DESCALZO, Miguel A et al.Seminars in arthritis and rheumatism. 2011, Vol 41, Num 1, pp 71-80, issn 0049-0172, 10 p.Article

Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysisORTEA, Ignacio; ROSCHITZKI, Bernd; GABRIEL OVALLES, Juan et al.Journal of proteomics (Print). 2012, Vol 77, pp 372-382, issn 1874-3919, 11 p.Article

A Broad Analysis of IL1 Polymorphism and Rheumatoid ArthritisJOHNSEN, Alyssa K; PLENGE, Robert M; BENOIST, Christophe et al.Arthritis and rheumatism. 2008, Vol 58, Num 7, pp 1947-1957, issn 0004-3591, 11 p.Article

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonistsCARMONA, Loreto; ANGEL DESCALZO, Miguel; PEREZ-PAMPIN, Eva et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 7, pp 880-885, issn 0003-4967, 6 p.Article

Variants Within STAT Genes Reveal Association with Anticitrullinated Protein Antibody-negative Rheumatoid Arthritis in 2 European PopulationsSEDDIGHZADEH, Maria; GONZALEZ, Antonio; DING, B. O et al.Journal of rheumatology. 2012, Vol 39, Num 8, pp 1509-1516, issn 0315-162X, 8 p.Article

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registryBUSQUETS, Noemí; TOMERO, Eva; DESCALZO, Miguel Angel et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 11, pp 1999-2004, issn 1462-0324, 6 p.Article

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumabWAGNER, Carrie L; VISVANATHAN, Sudha; BEUTLER, Anna et al.Annals of the rheumatic diseases. 2013, Vol 72, Num 1, pp 83-88, issn 0003-4967, 6 p.Article

Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0CARMONA, Loreto; DESCALZO, Miguel A; RUIZ-MONTESINOS, Dolores et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 85-92, issn 1462-0324, 8 p.Article

Large-Scale Analysis of Association Between GDF5 and FRZB Variants and Osteoarthritis of the Hip, Knee, and HandEVANGELOU, Evangelos; CHAPMAN, Kay; HALLDORSSON, Bjarni V et al.Arthritis and rheumatism. 2009, Vol 60, Num 6, pp 1710-1721, issn 0004-3591, 12 p.Article

Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy StudyGENOVESE, Mark C; MCKAY, James D; NASONOV, Evgeny L et al.Arthritis and rheumatism. 2008, Vol 58, Num 10, pp 2968-2980, issn 0004-3591, 13 p.Article

  • Page / 2